| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.39▼ | 0.38▲ | 0.39▼ | 0.36▲ | 0.36▲ |
| MA10 | 0.39▲ | 0.39▼ | 0.41▼ | 0.37▲ | 0.39▼ |
| MA20 | 0.39▼ | 0.41▼ | 0.38▲ | 0.35▲ | 0.50▼ |
| MA50 | 0.41▼ | 0.37▲ | 0.37▲ | 0.39▼ | 1.01▼ |
| MA100 | 0.41▼ | 0.38▲ | 0.35▲ | 0.51▼ | 1.75▼ |
| MA200 | 0.39▲ | 0.36▲ | 0.37▲ | 0.70▼ | 11.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.006▼ | -0.002▼ | 0.009▲ | 0.028▲ |
| RSI | 44.326▼ | 47.444▼ | 51.484▲ | 52.071▲ | 36.685▼ |
| STOCH | 62.566 | 15.079▼ | 10.141▼ | 47.262 | 25.523 |
| WILL %R | -50.299 | -91.847▼ | -86.096▼ | -42.733 | -61.892 |
| CCI | 48.398 | -58.584 | -83.007 | 86.840 | -38.331 |
|
Friday, May 15, 2026 05:21 AM
TriKE® remains ongoing, with additional updates anticipated in 2H 2026Phase 1 basket trial evaluating GTB-5550 ...
|
|
Thursday, May 14, 2026 06:41 AM
GT Biopharma Inc. (NASDAQ:GTBP) on Thursday dosed the first patient on a Phase 1 dose-escalation basket trial evaluating GTB-5550, its B7-H3-targeted NK cell engager for solid tumors expressing B7-H3.
|
|
Thursday, May 14, 2026 06:17 AM
GTB-5550 is now the 3rd TriKE® to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/05/26 | 0.4575 | 0.464 | 0.3782 | 0.3865 | 3,905,361 |
| 14/05/26 | 0.374 | 0.48 | 0.3709 | 0.4389 | 14,520,622 |
| 13/05/26 | 0.3168 | 0.3216 | 0.31 | 0.3127 | 358,632 |
| 12/05/26 | 0.3326 | 0.3365 | 0.3105 | 0.3226 | 606,217 |
| 11/05/26 | 0.38 | 0.3888 | 0.3422 | 0.3429 | 618,180 |
| 08/05/26 | 0.39 | 0.39 | 0.372 | 0.3752 | 486,944 |
| 07/05/26 | 0.4156 | 0.4156 | 0.38 | 0.3895 | 588,500 |
| 06/05/26 | 0.373 | 0.4176 | 0.373 | 0.4027 | 1,093,969 |
| 05/05/26 | 0.39 | 0.4166 | 0.37 | 0.3801 | 1,182,856 |
| 04/05/26 | 0.351 | 0.3871 | 0.35 | 0.3825 | 1,037,148 |
|
|
||||
|
|
||||
|
|